News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Dendreon Corporation Moving HQ to Selig Building on Waterfront
May 4, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Seattle Times -- Seattle biotech Dendreon, fresh off winning regulatory approval for its cancer therapy, confirmed Monday it's moving its headquarters and other local operations to a brand-new, bigger building.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
MORE ON THIS TOPIC
Layoffs
August biopharma layoffs impact just over 500, down 90% year over year
September 10, 2026
·
6 min read
·
Angela Gabriel
Layoff Tracker
Merck adds 53 to New Jersey chopping block
September 9, 2026
·
91 min read
·
BioSpace Editorial Staff
Manufacturing
Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision
September 9, 2026
·
2 min read
·
Nick Paul Taylor
FDA
Novo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander disease
September 9, 2026
·
1 min read
·
Jef Akst
